Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.

Various serum biomarkers have been developed for predicting head and neck squamous cell carcinoma (HNSCC) prognosis. However, none of them have been proven to be clinically significant. A recent study reported that the ratio of aspartate aminotransaminase (AST) to alanine aminotransaminase (ALT) had...

Full description

Bibliographic Details
Main Authors: Yukinori Takenaka, Norihiko Takemoto, Toshimichi Yasui, Yoshifumi Yamamoto, Atsuhiko Uno, Haruka Miyabe, Naoki Ashida, Kotaro Shimizu, Susumu Nakahara, Atshushi Hanamoto, Takahito Fukusumi, Takahiro Michiba, Hironori Cho, Masashi Yamamoto, Hidenori Inohara
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5061313?pdf=render